Apogee Therapeutics, Inc.

Ownership Transactions Reported by 10 Insiders

Symbol
APGE on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
221 Crescent St., Building 17, Suite 102 B, Waltham, MA

Insiders trading volume in the past year

Apogee Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Michael Henderson Chief Executive Officer, Director $82.1M -$3.6M -4.2% Nov 13, 2025
Carl Dambkowski Chief Medical Officer $15.9M -$2.71M -14.5% Nov 5, 2025
Nimish Shah Director $15M +$15M Oct 10, 2025
Jane Henderson Chief Financial Officer $13.7M -$295K -2.1% Nov 25, 2025
Mark C. McKenna Director $997K +$991K +15916% Jun 17, 2025
Andrew Gottesdiener Director Jun 17, 2025
Lisa Bollinger Director Jun 17, 2025
William Jones Director Jun 17, 2025
Fairmount Funds Management LLC Director Jun 17, 2025
Jennifer Fox Director Jun 17, 2025

Recent Insider Transactions by Companies or Individuals for Apogee Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.